Leadership

Daniel Griffing is Managing Partner of Griffing Speizer & Partners LLC. Most recently he served as Vice President and Head of Global Marketing for Orchard Therapeutics PLC from 2018 to 2020 a leading gene therapy company dedicated to transforming the lives of patients with serious and life threatening rare disease. Previously, Mr Griffing spent 20 years at Merck & Co., Inc in various commercial leadership roles across sales, finance, market access, new product planning and marketing in Global HQ, Region (Europe, Middle East, Africa) based in Zurich, Switzerland and Local (U.S. Market) assignments.

Mr. Griffing holds a BSc. in Business Administration from The College of New Jersey an M.B.A. from Saint Joseph's University and completed postgraduate education at The Wharton School of the University of Pennsylvania.

Louis Speizer is Managing Partner of Griffing Speizer & Partners LLC. He has over 30 years of biopharmaceutical marketing experience including 22 years at Merck & Co., Inc serving as New Product Lead for several therapeutic areas and most recently working at Orchard Therapeutics PLC with responsibility for marketing in-line & pipeline gene therapy products. He has significant experience with new product development and commercialization, strategic leadership, global market planning, business development and in-licensing evaluation.

Dr. Speizer holds an A.B. in physiology from UC Berkeley, a Ph.D. in physiology from the University of Virginia and was a post-doctoral fellow in pharmacology at the University of California San Diego School of Medicine.